Nasbio Pharma Private Limited
About Nasbio Pharma Private Limited
Data last updated:
Nasbio Pharma Private Limited is a private limited company based in Mangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24110KA2021PTC149340. Its GSTIN is 29AAHCN6917F1Z6 (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shameer Mohammed and Rainaz.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No. 16 – 2 – 73/20 Second Floor Bavas Complex, Bavas Complex T.S. No. 738/2A Kankanady Bypass Road Mangalore, Karnataka, India – 575002.
As per the financials filed for FY 2023, the company reported a revenue of ₹3.54 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.13 Lakh (net margin -60.2%) and EBITDA of -₹4,687 (EBITDA margin -1.3%).
As per MCA filings, the company has open charges of ₹65 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressDoor No. 16 – 2 – 73/20 Second Floor Bavas Complex, Bavas Complex T.S. No. 738/2A Kankanady Bypass Road Mangalore, Karnataka, India – 575002
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nasbio Pharma Private Limited
The main business activity of Nasbio Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nasbio Pharma Private Limited FY 2025 filings available
Nasbio Pharma Private Limited reported revenue of ₹3.54 Lakh (up 2630% YoY) for FY 2023.
Financial Statement Summary of Nasbio Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹3.54 Lakh | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹4,687 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹2.13 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Nasbio Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -1.3% | •••• |
| Net Profit Margin | -60.2% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nasbio Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nasbio Pharma Private Limited
Nasbio Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shameer Mohammed | Director | 12 Jul 2021 | 5 Years 3 Months | Current |
| Rainaz | Director | 17 Dec 2024 | 1 Years 10 Months | Current |
Auditor Details of Nasbio Pharma Private Limited
Nasbio Pharma Private Limited is audited by Shesham & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Shesham & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nasbio Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nasbio Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2024 | State Bank of India | ₹65 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Nasbio Pharma Private Limited
Nasbio Pharma Private Limited has a workforce of 0 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nasbio Pharma Private Limited
Nasbio Pharma Private Limited has 8 board changes on record since 2021: 5 appointments and 3 cessations. The latest: Rainaz was appointed as Director on 17 Dec 2024.
Credit Ratings, Litigation & Regulatory Alerts for Nasbio Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nasbio Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nasbio Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nasbio Pharma Private Limited
Nasbio Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCN6917F1Z6 | Karnataka | Active | 05 Oct 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nasbio Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nasbio Pharma Private Limited
Nasbio Pharma is an active private limited company based in Mangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 July 2021 (5+ years old) and is registered under CIN U24110KA2021PTC149340.
Nasbio Pharma reported revenue of ₹3.54 Lakh for FY 2023 (up 2630% YoY).
Nasbio Pharma has 2 current directors:
- Shameer Mohammed - Director
- Rainaz - Director
Nasbio Pharma reported a net loss of ₹2.13 Lakh (net margin -60.2%) and EBITDA of -₹4,687 (EBITDA margin -1.3%) for FY 2023, as per its filed financial statements.
The GSTIN of Nasbio Pharma is 29AAHCN6917F1Z6, registered in Karnataka.
The CIN (Corporate Identification Number) of Nasbio Pharma is U24110KA2021PTC149340. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nasbio Pharma was incorporated on 12 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Rainaz was appointed as Director on 17 Dec 2024. Rehana Shameer Mohammad ceased to be Director on 17 Dec 2024. Mohammed Nawaz ceased to be Director on 09 Jan 2024. Nasbio Pharma has 8 board changes on record in total.
The registered office of Nasbio Pharma is at Door No. 16 – 2 – 7320 Second Floor Bavas Complex, Bavas Complex T.S. No. 7382A Kankanady Bypass Road Mangalore, Karnataka, India – 575002.
Nasbio Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.